Does NATALIZUMAB Cause Post procedural infection? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Post procedural infection have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.1% of all adverse event reports for NATALIZUMAB.
71
Reports of Post procedural infection with NATALIZUMAB
0.1%
of all NATALIZUMAB reports
0
Deaths
57
Hospitalizations
How Dangerous Is Post procedural infection From NATALIZUMAB?
Of the 71 reports, 57 (80.3%) required hospitalization.
Is Post procedural infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Post procedural infection?
ADALIMUMAB (1,109)
ETANERCEPT (362)
METHOTREXATE (226)
INFLIXIMAB (223)
UPADACITINIB (188)
TOFACITINIB (184)
GOLIMUMAB (177)
VEDOLIZUMAB (166)
RISANKIZUMAB-RZAA (157)
USTEKINUMAB (150)
Which NATALIZUMAB Alternatives Have Lower Post procedural infection Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK